ArticleScientific reports2026
Encapsulation of colistin using hyaluronic acid and PVA-PSS polymeric nanocarriers for enhanced drug delivery: a molecular dynamics simulation study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colistin (polymyxin E) is an effective antibiotic against Gram-negative bacteria, but its clinical use is limited due to its high toxicity. Targeted drug delivery, which has made significant progress in reducing drug toxicity in recent years, could be an ideal approach to mitigate the nephrotoxicity and neurotoxicity associated with this drug. However, the complexity of drug design and manufacturing remains a major challenge in the pharmaceutical industry. To address this, we investigated polymeric drug delivery systems for colistin encapsulation using molecular dynamics simulations. In this study, the MARTINI 3 force field within GROMACS 2022 software was employed to model and simulate various systems, including unmodified hyaluronic acid (HA), HA modified with two and four hydrophobic groups, and a combination of polyvinyl alcohol (PVA) and polystyrene sulfonate (PSS). Structural analysis of the systems was performed based on indices such as root-mean-square deviation (RMSD), radius of gyration (Rg), radial distribution function (RDF), and solvent-accessible surface area (SASA). The results indicated that hydrophobic modification of HA increased aggregation, reduced the radius of gyration, and enhanced the system's stability in the presence of colistin. Among the modified systems, HA with four hydrophobic groups (HA(4)) exhibited the highest structural stability. Additionally, the PVA-PSS polyelectrolyte complex displayed stable behavior, formed a bilayer structure, and demonstrated effective interactions with the drug. Targeted chemical modifications and the use of hybrid polymers can facilitate the design of stable, efficient, and controllable systems for colistin delivery. This study provides a viable pathway for the development of safe nanocarriers with high encapsulation efficiency under realistic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.